Related references
Note: Only part of the references are listed.Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
J. J. Rouby et al.
INTENSIVE CARE MEDICINE (2020)
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria
A. N. Kristoffersson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Nebulized Antibiotics Epithelial Lining Fluid Concentrations Overestimate Lung Tissue Concentrations
Jean-Jacques Rouby et al.
ANESTHESIOLOGY (2019)
The Old and the New Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
Ilias Karaiskos et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia
Adela Benitez-Cano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Size Distribution of Colistin Delivery by Different Type Nebulizers and Concentrations During Mechanical Ventilation
Ching-Yi Liu et al.
PHARMACEUTICS (2019)
NONMEM Tutorial Part I: Description of Commands and Options, With Simple Examples of Population Analysis
Robert J. Bauer
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia
Nathaniel J. Rhodes et al.
CURRENT INFECTIOUS DISEASE REPORTS (2018)
Aerosol Therapy for Pneumonia in the Intensive Care Unit
Charles-Edouard Luyt et al.
CLINICS IN CHEST MEDICINE (2018)
Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model
Yu-Wei Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study
D. Koulenti et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Colistin: still a lifesaver for the 21st century?
Ilias Karaiskos et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges
G. Poulakou et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
An automated sampling importance resampling procedure for estimating parameter uncertainty
Anne-Gaelle Dosne et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2017)
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients
Alan Forrest et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Development and validation of a UHPLC-MS/MS assay for colistin methanesulphonate (CMS) and colistin in human plasma and urine using weak-cation exchange solid-phase extraction
Miao Zhao et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Mucin Binding Reduces Colistin Antimicrobial Activity
Johnny X. Huang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
Ilias Karaiskos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia
Lila Bouadma et al.
CRITICAL CARE MEDICINE (2015)
Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
Matthieu Boisson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Estimation of renal function in the intensive care unit: the covert concepts brought to light
Sham Sunder et al.
JOURNAL OF INTENSIVE CARE (2014)
Effect of Pulmonary Surfactant on Antimicrobial Activity In Vitro
R. Schwameis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose
R. J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
Ami F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
Zoe E. Athanassa et al.
INTENSIVE CARE MEDICINE (2012)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers
W. Couet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The airway epithelium: more than just a structural barrier
Anthony Tam et al.
Therapeutic Advances in Respiratory Disease (2011)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Preclinical models for pulmonary drug delivery
Claudia A. Fernandes et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Teresa C. Horan et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Share Paper
